… , reported data on combination chemotherapy for small cell lung carcinoma were limited to
… reports successfully utilizing combination chemotherapy for small cell lung carcinoma. Two …

… , and lung carcinoma investigators have not been able to conclude whether combination
chemotherapy yielded a survival advantage over single agent chemotherapy in patients with …

… alone to combined radiotherapy and chemotherapy in unresectable squamous cell and large
cell lung carcinoma. Radiation dose was 65 Gy in both groups and chemotherapy included …

… of combination chemotherapy regimens in metastatic (stage IV) nonsmall-cell lung cancer
(… regimens in patients with inoperable non-small cell lung carcinoma (EST 2575) Generation I…

… were identified and combinations of drugs developed. Combination chemotherapy was found
… Despite these developments, in extensive disease, standard chemotherapy combinations, …

… In the current study, combination chemotherapy comprised of oral UFT and cisplatin was
confirmed to be a moderately effective regimen for NSCLC and to be associated with an …

… The objective of this Phase II study was to evaluate the concept of sequential chemotherapy
in the treatment of patients with advanced nonsmall cell lung carcinoma (NSCLC) by the …

Chemotherapy (doxorubicin, cyclophosphamide, and vincristine) was given in a sequential …
and brain to 358 patients with small-cell lung carcinoma (extensive disease in 250, limited in …

… combination of radiotherapy and chemotherapy in nonresectable squamous cell and large-cell
lung carcinoma… The radiation dose was 65 Gy in each group, and chemotherapy included …

… of disease 5 years or more after combination chemotherapy (cyclophosphamide, vincristine,
ad… The use of combination chemotherapy in the treatment of small cell carcinoma of lung …